Valuation: PolyPeptide Group AG

Market Cap 1.45B 1.61B 1.32B 1.21B 2.27B 152B 2.35B 15.94B 6.36B 80.91B 6.06B 5.93B 255B P/E 2026 *
53.9x
P/E 2027 * 28.6x
Enterprise Value 1.55B 1.73B 1.41B 1.29B 2.43B 162B 2.51B 17.05B 6.8B 86.56B 6.48B 6.34B 273B EV / Sales 2026 *
3.08x
EV / Sales 2027 * 2.74x
Free-Float
98.54%
Yield 2026 *
-
Yield 2027 * 0.15%
1 day-1.11%
1 week-4.64%
Current month-4.64%
1 month-8.77%
3 months-8.87%
6 months-1.72%
Current year+53.45%
1 week 40.05
Extreme 40.05
43.95
1 month 40.05
Extreme 40.05
44.3
Current year 23.1
Extreme 23.1
50.1
1 year 21.8
Extreme 21.8
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
146
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 2023-04-11
Director of Finance/CFO 54 2024-01-01
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 2005-12-31
Chairman 69 2021-03-31
Director/Board Member 62 2020-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
11/13/23 Buy 2,500 0.0075%
10/12/23 Buy 159,959 0.4829%
4/6/23 Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%-4.64%+71.52%+97.10% 1.61B
-0.79%-4.48%+46.48%+125.69% 1,206B
+1.43%+1.11%+48.05%+83.05% 665B
+1.07%-1.21%+32.92%+104.92% 515B
-0.36%-3.25%+45.42%+65.10% 381B
-0.14%-1.87%+70.06%+41.09% 362B
-0.78%-0.52%+30.47%+58.09% 307B
-0.80%-0.21%+7.98%+36.17% 289B
+0.03%-1.20%+43.79%+69.83% 249B
-0.41%-2.22%+40.43%+107.03% 207B
Average -0.19%-1.85%+43.71%+78.81% 418.14B
Weighted average by Cap. -0.04%-1.96%+42.72%+88.12%

Financials

2026 *2027 *
Net sales 502M 560M 459M 419M 789M 52.61B 814M 5.53B 2.2B 28.07B 2.1B 2.06B 88.61B 576M 642M 526M 481M 905M 60.37B 934M 6.35B 2.53B 32.21B 2.41B 2.36B 102B
Net income 23.5M 26.21M 21.48M 19.61M 36.95M 2.46B 38.11M 259M 103M 1.31B 98.37M 96.26M 4.15B 45.23M 50.43M 41.34M 37.73M 71.09M 4.74B 73.33M 498M 199M 2.53B 189M 185M 7.98B
Net Debt 101M 113M 92.27M 84.23M 159M 10.58B 164M 1.11B 443M 5.65B 423M 413M 17.82B 131M 146M 120M 109M 206M 13.72B 212M 1.44B 575M 7.32B 548M 536M 23.11B
Projected Income Statement - Annual - PolyPeptide Group AG
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,460
Date Price Change Volume
26-11-06 CHF 40.05 -1.11% 21,455
26-11-05 CHF 40.50 -2.06% 17,693
26-11-04 CHF 41.35 -2.93% 24,358
26-11-03 CHF 42.60 +3.02% 22,945
26-11-02 CHF 41.35 -1.55% 27,079
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - PolyPeptide Group AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
43.82EUR
Average target price
46.32EUR
Spread / Average Target
+5.70%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PolyPeptide Group AG
  1. Stock Market
  2. Stocks
  3. PPGN Stock